PUMA BIOTECHNOLOGY, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2015 | -116.2% | -116.2% | -99.8% |
| FY2016 | -131.5% | -131.5% | -109.2% |
| FY2017 | -547.7% | -286.9% | -176.4% |
| FY2018 | -331.1% | -61.0% | -43.8% |
| FY2019 | -432.9% | -67.2% | -32.2% |
| FY2020 | 1,008.1% | -76.8% | -24.6% |
| FY2021 | 1,190.8% | -30.8% | -12.9% |
| FY2022 | 0.0% | 0.0% | 0.0% |
| FY2023 | 40.4% | 18.1% | 9.4% |
| FY2024 | 32.9% | 26.6% | 14.2% |
| FY2025 | 23.9% | 23.9% | 14.4% |